Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costantine Albany

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|March 17, 2020
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell TumorsKevin Juan Zhang, Nasser H Hanna, Sandra K Althouse, et al.
Cancer|July 14, 2021
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantationVaibhav Agrawal, Rafat Abonour, Mohammad Abu Zaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell TumorFadi Taza, Michal Chovanec, Anna Snavely, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Low CD34<sup>+</sup> Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell TumorsMustafa A Hyder, W Scott Goebel, Kirsten D Ervin, et al.
Transfusion|April 16, 2008
Plasmapheresis in asparaginase-induced hypertriglyceridemiaElizabeth M Kfoury-Baz, Rabih A Nassar, Rita F Tanios, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell TumorsAndrea Necchi, Gregory R Pond, Nicola Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2018
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factorsChristoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2020
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue MicrodissectionLiang Cheng, Steven A Mann, Antonio Lopez-Beltran, et al.
The Prostate|December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate CancerAjjai Alva, Luke Nordquist, Stephanie Daignault, et al.
International Journal of Molecular Sciences|April 30, 2021
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell LinesSilvia Schmidtova, Katarina Kalavska, Veronika Liskova, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|March 17, 2020
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell TumorsKevin Juan Zhang, Nasser H Hanna, Sandra K Althouse, et al.
Cancer|July 14, 2021
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantationVaibhav Agrawal, Rafat Abonour, Mohammad Abu Zaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell TumorFadi Taza, Michal Chovanec, Anna Snavely, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Low CD34<sup>+</sup> Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell TumorsMustafa A Hyder, W Scott Goebel, Kirsten D Ervin, et al.
Transfusion|April 16, 2008
Plasmapheresis in asparaginase-induced hypertriglyceridemiaElizabeth M Kfoury-Baz, Rabih A Nassar, Rita F Tanios, et al.
Clinical Genitourinary Cancer|September 6, 2016
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell TumorsAndrea Necchi, Gregory R Pond, Nicola Nicolai, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2018
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factorsChristoph Seidel, Gedske Daugaard, Alexey Tryakin, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2020
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue MicrodissectionLiang Cheng, Steven A Mann, Antonio Lopez-Beltran, et al.
The Prostate|December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate CancerAjjai Alva, Luke Nordquist, Stephanie Daignault, et al.
International Journal of Molecular Sciences|April 30, 2021
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell LinesSilvia Schmidtova, Katarina Kalavska, Veronika Liskova, et al.
Pageof 7